ENO2 and cancer: Likewise, Aydn and Sezgintürk developed an ITO-based EI for detecting NSE, a cancer biomarker specific for a variety of malignancies such as lung adenocarcinoma, squamous cell carcinoma, skin cancer, breast cancer, prostate cancer etc. with a LOD of 6.1 fg/mL (Figure 4) [72].